Clinical Role - Specialty Pharmacy
Pharmacy Times® is a leader in providing expert insights and clinical updates to specialty pharmacists and reaches more than 200,000 pharmacy professionals in total.
Key opinion leaders consider their first-line therapy options for treatment-naïve patients with chronic lymphocytic leukemia.
Erlotinib taken with gemcitabine was approved by the FDA for locally advanced, inoperable, or metastatic pancreatic cancer in 2005.
One in 8 women will develop breast cancer within their lifetime, making it the most commonly diagnosed cancer among women.
A new study found disturbing evidence that black cancer survivors are more likely to face financial hardship on high deductible health plans than their white counterparts.
Cytomegalovirus Disease Prevention in High-Risk Liver Transplant Patients: Preemptive Therapy or Prophylaxis?
Organ transplants from seropositive donors carry a high risk of infection from the transplanted organ.
A virtual symposium held in conjunction with the Asembia Specialty Pharmacy Summit focused on psoriatic arthritis.
By 2050, statisticians indicated that approximately 22 million people will be affected by macular degeneration or wet AMD.
Dravet syndrome is a life-threatening, rare, and chronic form of epilepsy and is often characterized by severe, unrelenting seizures despite medical treatment, according to the FDA press release.
The pharmaceutical industry is already seeing the immense benefit of AI and machine-learning technology.
There has been growing evidence supporting new therapeutic approaches for this heterogenous group of diseases.
Key opinion leaders discuss trials focusing on patient populations with newly diagnosed chronic lymphocytic leukemia (CLL).
Many companies are working with health systems to transition patients from the hospital to in-home care as quickly as possible.